We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$162M
Cap. Flow
+$141M
Cap. Flow %
13.21%
Top 10 Hldgs %
37.33%
Holding
532
New
105
Increased
323
Reduced
47
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.31M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.32M
3
NVDA icon
NVIDIA
NVDA
+$6.63M
4
MSFT icon
Microsoft
MSFT
+$6.29M
5
UGL icon
ProShares Ultra Gold
UGL
+$5.95M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.72M
2
PDD icon
Pinduoduo
PDD
+$4.15M
3
PG icon
Procter & Gamble
PG
+$2.96M
4
SNPS icon
Synopsys
SNPS
+$2.64M
5
AMAT icon
Applied Materials
AMAT
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 38.03%
2 Healthcare 25.43%
3 Consumer Discretionary 12.38%
4 Communication Services 10.24%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIS icon
451
Walt Disney
DIS
$178B
$49.6K ﹤0.01%
444
-4,199
-90% -$441K
INBX icon
452
Inhibrx
INBX
$1.44B
$47.3K ﹤0.01%
+3,069
New +$46.7K
LXEO icon
453
Lexeo Therapeutics
LXEO
$382M
$46.1K ﹤0.01%
+7,011
New +$55.2K
IGMS
454
DELISTED
IGM Biosciences
IGMS
$44.2K ﹤0.01%
+7,226
New +$85.9K
TXRH icon
455
Texas Roadhouse
TXRH
$14.1B
$44K ﹤0.01%
244
– –
MGNX icon
456
MacroGenics
MGNX
$256M
$43.3K ﹤0.01%
13,308
+1,244
+10% +$4.48K
AMRN
457
Amarin Corp
AMRN
$297M
$41.2K ﹤0.01%
4,243
+395
+10% +$4.23K
CMPS
458
Compass Pathways
CMPS
$1.97B
$40.8K ﹤0.01%
+10,782
New +$54.7K
FATE icon
459
Fate Therapeutics
FATE
$317M
$39.8K ﹤0.01%
+24,150
New +$60.9K
ACRV icon
460
Acrivon Therapeutics
ACRV
$73.6M
$39.7K ﹤0.01%
+6,602
New +$48K
ALEC icon
461
Alector
ALEC
$240M
$39.2K ﹤0.01%
20,765
+2,047
+11% +$7.71K
TVGN icon
462
Tevogen Inc. Common Stock
TVGN
$27.3M
$38.2K ﹤0.01%
+742
New +$48.3K
LYEL icon
463
Lyell Immunopharma
LYEL
$347M
$37.9K ﹤0.01%
2,960
+498
+20% +$9.87K
INZY
464
DELISTED
Inozyme Pharma
INZY
$37.7K ﹤0.01%
+13,621
New +$51.8K
H icon
465
Hyatt Hotels
H
$16.8B
$37.7K ﹤0.01%
240
– –
SCPH
466
DELISTED
scPharmaceuticals
SCPH
$37.6K ﹤0.01%
+10,610
New +$40.6K
MRSN
467
DELISTED
Mersana Therapeutics
MRSN
$37.5K ﹤0.01%
+1,048
New +$54.2K
NKTX icon
468
Nkarta
NKTX
$171M
$37.3K ﹤0.01%
+14,963
New +$46.2K
KYTX icon
469
Kyverna Therapeutics
KYTX
$489M
$34.2K ﹤0.01%
+9,154
New +$43.9K
SLDB icon
470
Solid Biosciences
SLDB
$971M
$33.9K ﹤0.01%
+8,472
New +$46.5K
STRO icon
471
Sutro Biopharma
STRO
$353M
$32.2K ﹤0.01%
+1,748
New +$53.4K
GSK icon
472
GSK
GSK
$101B
$32.2K ﹤0.01%
338
-54,007
-99% -$1.94M
TSVT
473
DELISTED
2seventy bio
TSVT
$32.2K ﹤0.01%
+10,939
New +$44.9K
TCRX icon
474
TScan Therapeutics
TCRX
$50.5M
$31.6K ﹤0.01%
+10,410
New +$47.2K
DECK icon
475
Deckers Outdoor
DECK
$12.4B
$30.5K ﹤0.01%
150
– –
17 18
19
20 21

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2024 Portfolio in Review

As of Q4 2024, China Universal Asset Management Company held 532 positions worth $1.07B, up 18% from $907M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

China Universal Asset Management Company deployed $141M of net new capital in Q4 2024, opening 105 new positions and adding to 323 existing holdings. Its largest new stake was Astera Labs: 26,000 shares worth $3.44M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Pinduoduo, an estimated $4.15M trimmed.

  • China Universal Asset Management Company's largest Q4 2024 buy was Astera Labs: 26,000 shares worth $3.44M.
  • China Universal Asset Management Company added most to Apple in Q4 2024, an estimated $9.31M increase.
  • China Universal Asset Management Company's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $4.15M.
  • China Universal Asset Management Company fully exited Alibaba in Q4 2024, selling an estimated $5.72M.
  • China Universal Asset Management Company's ten largest holdings make up 37% of its $1.07B portfolio in Q4 2024.
  • China Universal Asset Management Company opened 105 new positions and closed 36 in Q4 2024.
  • China Universal Asset Management Company's portfolio value rose 18% quarter-over-quarter to $1.07B.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.